RESUMEN
This paper investigates the impact of legislative changes allowing nurse practitioners to prescribe schedule II controlled substances independently. We find that this legal environment is associated with an increase in treatment admissions for opioid misuse and a decrease in opioid related mortality only when Mandatory Prescription Drugs Monitoring Programs are in place.
Asunto(s)
Analgésicos Opioides/administración & dosificación , Enfermeras Practicantes/legislación & jurisprudencia , Autonomía Profesional , Alcance de la Práctica/legislación & jurisprudencia , Sobredosis de Droga/mortalidad , Sobredosis de Droga/prevención & control , Prescripciones de Medicamentos , Femenino , Humanos , Masculino , Persona de Mediana EdadRESUMEN
Despite the significant cost of prescription (Rx) drug abuse and calls from policymakers for effective interventions, there is limited research on the effects of policies intended to limit such abuse. This study estimates the effects of prescription drug monitoring (PDMP) programs, which constitute a key policy targeting access to non-medical use of Rx drugs. Based on objective indicators of abuse as measured by substance abuse treatment admissions and mortality related to Rx drugs, estimates do not suggest any substantial effects of instituting an operational PDMP. We find, however, that mandatory-access provisions, which raised PDMP utilization rates by actually requiring providers to query the PDMP prior to prescribing a controlled drug, are significantly associated with a reduction in Rx drug abuse. The effects are driven primarily by a reduction in opioid abuse, generally strongest among young adults (ages 18 to 24), and underscore important dynamics in the policy response. Robustness checks are consistent with a causal interpretation of these effects. We also assess potential spillovers of mandatory PDMPs on the use of other illicit drugs and find a complementary reduction in admissions related to cocaine and marijuana abuse.
Asunto(s)
Programas Obligatorios , Desvío de Medicamentos bajo Prescripción/prevención & control , Mal Uso de Medicamentos de Venta con Receta/prevención & control , Programas de Monitoreo de Medicamentos Recetados/estadística & datos numéricos , Trastornos Relacionados con Sustancias/epidemiología , Adolescente , Adulto , Analgésicos Opioides , Cannabis , Cocaína , Sobredosis de Droga/mortalidad , Heroína , Humanos , Drogas Ilícitas , Persona de Mediana Edad , Gobierno Estatal , Estados Unidos , Adulto JovenRESUMEN
Using U.S. Natality data for 1996 through 2009 and an event analysis specification, we investigate the dynamics of the effects of state insurance contraceptive mandates on births and measures of parental investment: prenatal visits, non-marital childbearing, and risky behaviors during pregnancy. We analyze outcomes separately by age, race, and ethnicity. Among young Hispanic women, we find a 4% decline in the birth rate. There is evidence of a decrease in births to single mothers, consistent with increased wantedness. We also find evidence of selection into motherhood, which could explain the lack of a significant effect on birth outcomes.